التفاصيل البيبلوغرافية
| العنوان: |
Clinical Integration of Next Generation Sequencing: Coverage and Reimbursement Challenges. |
| المؤلفون: |
Deverka, Patricia A., Dreyfus, Jennifer C. |
| المصدر: |
Journal of Law, Medicine & Ethics; Fall2014 Supplement, Vol. 42, p22-41, 20p, 1 Diagram |
| مصطلحات موضوعية: |
GENOMICS, MOLECULAR diagnosis, MOLECULAR biology, MEDICAL technology, ROUTINE diagnostic tests, GOVERNMENT policy, MEDICAL genetics laws, BIOTECHNOLOGY, HUMAN genome, INSURANCE, HEALTH insurance, MOLECULAR pathology, GENETIC testing, HEALTH insurance reimbursement, MEDICAL coding, INDIVIDUALIZED medicine, SEQUENCE analysis |
| مصطلحات جغرافية: |
UNITED States |
| مستخلص: |
Public and private payers face complex decisions regarding whether, when, and how to cover and reimburse for next generation sequencing (NGS)-based tests. Yet a predictable reimbursement pathway is critical both for patient access and incentives to provide the market with better clinical evidence. While preliminary data suggests that payers will use similar evidentiary standards as those used to evaluate established molecular diagnostic tests, the volume and complexity of information generated by NGS raises a host of additional considerations for payers that are specific to this technology. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Law, Medicine & Ethics is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
